(Q46036413)

English

Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance.

scientific article published on 22 April 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19395079

Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance. (English)

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19395079

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ryuzo Kawamori

1

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19395079

Naoko Tajima

2

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19395079

Yasuhiko Iwamoto

3

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19395079

Atsunori Kashiwagi

4

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19395079

Kazuaki Shimamoto

5

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19395079

Kohei Kaku

6

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19395079

Voglibose Ph-3 Study Group

7

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19395079

language of work or name

0 references

publication date

22 April 2009

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19395079

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19395079

373

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19395079

9675

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19395079

1607-1614

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19395079

Diabetes in America: epidemiology and scope of the problem

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical implications of impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

International Diabetes Federation: a consensus on Type 2 diabetes prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Is There a Role for ??-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of voglibose on glycemic excursions, insulin secretion, and insulin sensitivity in non-insulin-treated NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy of alpha-glucosidase inhibitor and a sulfonylurea compound prolongs the duration of good glycemic control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of two alpha-glucosidase inhibitors, voglibose and acarbose, on postprandial hyperglycemia correlates with subjective abdominal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Tutorial in biostatistics: competing risks and multi-state models

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960222-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(09)60222-1

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19395079

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19395079

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46036413&oldid=2104992016"